GLYENCE Co., Ltd. is a venture company of the university departure established on February 3, 2004 based on the science and technology seeds brought up by Prof. Koichi Kato and Co Takahashi professors emeritus in the Nagoya City University graduate school pharmacology research course that is the specialist of the sugar chain structure analysis. Be the sugar chain analysis data base "GALAXY" and the construction of N type sugar chain library in which it reaches about 600 kinds extracted from the animal cell, the insect cell, and the plant, etc. , and the feature of GLYENCE to analyze it of the reference that is a lot of unparalleled standard goods sugar chains including the inside and outside the country prompt and accurate. The structure to use MALDI-TOF MS and NMR of an unknown sugar chain that doesn't exist in the data base can be analyzed. Moreover, because the sugar chain professional can be quantitatively wholly filed, the organization and the cell are useful also for the sugar chain biomarker search of the disease. The trust service of the sugar chain structure analysis is being done as a drug development basic business based on such a technology now, and it answers wide range of needs of the search for the biomarker that becomes the drug development seeds and the quality control etc. of the medicine made of the living thing. The analytical result can be passed within about four weeks after the sample is gotten from the customer.
Moreover, it is advanced not only a drug development basic business but also to aim at the drug development that uses the sugar chain, and to do a joint research with teachers in the sugar chain science Nagoya base.